BIP_EG-01-1962-03

Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage

This study compares EG-1962 (nimodipine microparticles) to enteral nimodipine (capsules or tablets) in the treatment of aneurysmal subarachnoid hemorrhage.

Key Eligibilities:
-Patients ages 18 to 75.
-Ruptured saccular aneurysm confirmed by angiography and repaired by neurosurgical clipping or endovascular coiling.
-External ventricular drain in place.
-Subarachnoid hemorrhage on computed tomography (CT) scan of grade 2-4 on the modified Fisher scale.

**Other protocol-defined inclusion/exclusion criteria may apply. Please click on the NCT Number (below) to learn more about the study at clinicaltrials.gov.**
Phase III
NCT02790632
Neurosciences
Stroke
Lilith Judd, M.D.
Edge Therapeutics
Kristen Reid
  • Providence St. Vincent Medical Center